{
  "id": 181314,
  "name": "ABBOTT (FORMERLY KNOWN AS ALERE INC.)",
  "slug": "abbott-formerly-known-as-alere-inc",
  "state": "MA",
  "description": "Alere manufactures innovative point of care health care diagnostics",
  "totalSpending": 2560000,
  "filings": 32,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 240000
    },
    {
      "year": 2019,
      "income": 320000
    },
    {
      "year": 2020,
      "income": 320000
    },
    {
      "year": 2021,
      "income": 320000
    },
    {
      "year": 2022,
      "income": 400000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 320000
    },
    {
      "year": 2025,
      "income": 320000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH",
    "PETER FISE",
    "LAURA FRIEDEL",
    "PARICK CARROLL"
  ],
  "issues": [
    "HCR",
    "TAX",
    "MMM",
    "BUD",
    "TRD",
    null,
    "ENV"
  ],
  "sampleDescriptions": [
    "medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids\nPL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017",
    "S. 108- Medical Device Access and Innovation Protection Act\nH.R. 184 - Protect Medical Innovation Act of 2017\nH.R. 1- Tax Cuts and Jobs Act",
    "Medicare reimbursement\nMedicare competitive bidding for diabetic supplies\nH.R. 3921 - Healthy Kids Act\nS. 1827 - Kids Act of 2017\nOpioids\ndiagnostics",
    "H.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018",
    "H.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution",
    "S. 108- Medical Device Access and Innovation Protection Act\nH.R. 184 - Protect Medical Innovation Act of 2017\nH.R. 1- Tax Cuts and Jobs Act\nH.R. 195 - CR",
    "medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids\nPL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act",
    "Medicare reimbursement\nMedicare competitive bidding for diabetic supplies\nH.R. 3921 - Healthy Kids Act\nS. 1827 - Kids Act of 2017\nOpioids\ndiagnostics\nPAMA, CLIA\nSelf-testing\nNutrition",
    "H.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution\nH.R. 695 - Department of Defense Appropriations Act",
    "S. 692 - Protect Medical Innovation Act of 2019\nmedical device tax",
    "medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids, software as a medical device, interoperability, cybersecurity, data privacy",
    "Medicare reimbursement\nMedicare competitive bidding for diabetic supplies\nOpioids\ndiagnostics\nPAMA, CLIA\nSelf-testing\nNutrition",
    "Appropriations, budget\nH.J.Res. 31, Consolidated Appropriations Act, 2019",
    "medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids, software as a medical device, interoperability, cybersecurity, data privacy, effective pain management\n\nS. 1895 - Lower Health Care Costs Act",
    "Medicare reimbursement\nMedicare competitive bidding for diabetic supplies\nOpioids\ndiagnostics\nPAMA, CLIA\nSelf-testing\nNutrition\nMalnutrition and hospital readmissions",
    "Appropriations, budget\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020",
    "H.R. 2207/S. 692 - Protect Medical Innovation Act of 2019\nmedical device tax",
    "Medicare reimbursement\nMedicare competitive bidding for diabetic supplies\nOpioids\ndiagnostics\nPAMA, CLIA\nSelf-testing\nNutrition\nMalnutrition and hospital readmissions\nEmerging medical device technology",
    "medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids, software as a medical device, interoperability, cybersecurity, data privacy, effective pain management, Sunshine\n\nS. 1895 - Lower Health Care Costs Act",
    "Appropriations, budget\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 33,
  "trajectory": "growing",
  "yearsActive": 8,
  "avgAnnualSpending": 320000,
  "peakYear": 2022,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 6
}